Evidence comparison
How they actually compare on the evidence — trial volume, literature, mechanism, and our honest confidence grade. Higher counts reflect research attention, not proof of superiority.
Western · Senolytic · flavonoid
漆黄素
Early / limited human trials
Key active: Fisetin (flavonoid senolytic)
Strong animal senolytic data; human trials early
Fisetin selectively clears senescent cells and extended lifespan and healthspan in aged mice; human senolytic trials are early-stage, making this promising-but-unproven.
Full Fisetin evidence →Western · Flavonoid
槲皮素
Extensive human-trial evidence
Key active: Quercetin (flavonoid)
Early human senolytic trials (D+Q); anti-inflammatory data
Quercetin modulates inflammation and, combined with dasatinib (D+Q), is the most-studied senolytic regimen in early human trials for senescence-associated conditions.
Full Quercetin evidence →Need this for a decision?
We build evidence-graded comparisons for formulators, brands, clinics, and investors.
Informational only — not medical advice or a recommendation to take either. Trial and literature counts are registry/database matches and include endpoints beyond longevity. See each ingredient page for sources.